Bob Kramer, Emergent BioSolutions CEO

It looks like the fi­nal round of Emer­gen­t's As­traZeneca Covid-19 dos­es have been re­leased

Four more batch­es of As­traZeneca’s Covid-19 vac­cine that were made at Emer­gent BioSo­lu­tions’ Bal­ti­more plant have been cleared for ship­ment out­side the US by the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.